• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒减毒活疫苗:过去与未来的发展方向

Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions.

作者信息

Tang Yan-Dong, Li Yuming, Cai Xue-Hui, Yin Xin

机构信息

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, 150069, China.

Heilongjiang Provincial Research Center for Veterinary Biomedicine, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, 150069, China.

出版信息

Adv Sci (Weinh). 2025 Jan;12(3):e2407241. doi: 10.1002/advs.202407241. Epub 2024 Dec 6.

DOI:10.1002/advs.202407241
PMID:39639853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11744563/
Abstract

Viral infections continue to pose a significant threat to the health of both humans and animals. Currently, live attenuated vaccines (LAVs) remain the most efficacious and widely utilized tool for combating viral infections. Conventional LAVs involve the adaptation of virulent viruses to novel hosts, cell cultures, or suboptimal environments, resulting in a reduction in pathogenicity while retaining immunogenicity. This process entails directed evolution of the virus to enhance its replication efficiency under these modified conditions. In this review, the development of traditional animal-adapted and cold-adapted LAVs is specially discussed. Additionally, the factors that contribute to virus attenuation from a viral lifecycle perspective are summarized. Finally, we propose future directions for next-generation LAVs.

摘要

病毒感染继续对人类和动物的健康构成重大威胁。目前,减毒活疫苗(LAVs)仍然是对抗病毒感染最有效且应用最广泛的工具。传统的减毒活疫苗涉及使强毒病毒适应新宿主、细胞培养物或次优环境,从而在保留免疫原性的同时降低致病性。这个过程需要对病毒进行定向进化,以提高其在这些改变后的条件下的复制效率。在这篇综述中,特别讨论了传统的动物适应型和冷适应型减毒活疫苗的发展。此外,从病毒生命周期的角度总结了导致病毒减毒的因素。最后,我们提出了下一代减毒活疫苗的未来发展方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21b/11744563/61a3b2a9a70f/ADVS-12-2407241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21b/11744563/4b85e3c0f8b3/ADVS-12-2407241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21b/11744563/61a3b2a9a70f/ADVS-12-2407241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21b/11744563/4b85e3c0f8b3/ADVS-12-2407241-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21b/11744563/61a3b2a9a70f/ADVS-12-2407241-g003.jpg

相似文献

1
Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions.病毒减毒活疫苗:过去与未来的发展方向
Adv Sci (Weinh). 2025 Jan;12(3):e2407241. doi: 10.1002/advs.202407241. Epub 2024 Dec 6.
2
Polymerase Mechanism-Based Method of Viral Attenuation.基于聚合酶机制的病毒减毒方法。
Methods Mol Biol. 2016;1349:83-104. doi: 10.1007/978-1-4939-3008-1_6.
3
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.预先存在的抗体对活病毒疫苗的影响。
Viruses. 2020 May 8;12(5):520. doi: 10.3390/v12050520.
4
Rationalizing the development of live attenuated virus vaccines.使活减毒病毒疫苗的开发合理化。
Nat Biotechnol. 2010 Jun;28(6):573-9. doi: 10.1038/nbt.1635. Epub 2010 Jun 7.
5
Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.通过对毒力决定因素的有针对性突变,理性设计一种减毒活的东部马脑炎病毒疫苗。
PLoS Pathog. 2019 Feb 11;15(2):e1007584. doi: 10.1371/journal.ppat.1007584. eCollection 2019 Feb.
6
Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.在非结构蛋白10、14、15和16以及大分子结构域内含有突变的重组传染性支气管炎病毒可提供针对同源攻击的完全保护。
J Virol. 2025 Apr 15;99(4):e0166324. doi: 10.1128/jvi.01663-24. Epub 2025 Feb 27.
7
Serial cell culture passaging led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain.连续细胞传代导致一种强毒猪德尔塔冠状病毒株的完全衰减和特征变化。
J Virol. 2024 Aug 20;98(8):e0064524. doi: 10.1128/jvi.00645-24. Epub 2024 Jul 16.
8
Should the world collaborate imminently to develop neglected live-attenuated vaccines for COVID-19?全球是否应立即合作开发针对 COVID-19 的被忽视的减毒活疫苗?
J Med Virol. 2022 Jan;94(1):82-87. doi: 10.1002/jmv.27335. Epub 2021 Sep 21.
9
Genetic stability of live-attenuated Zika vaccine candidates.减毒活 Zika 疫苗候选物的遗传稳定性。
Antiviral Res. 2019 Nov;171:104596. doi: 10.1016/j.antiviral.2019.104596. Epub 2019 Sep 4.
10
Potency control of modified live viral vaccines for veterinary use.兽用减毒活疫苗的效力控制
Vaccine. 1996 Jan;14(1):13-8. doi: 10.1016/0264-410x(95)00177-3.

引用本文的文献

1
Highly efficient gene editing of using CRISPR/Cas9 combined with FACS.使用CRISPR/Cas9结合荧光激活细胞分选术(FACS)进行高效基因编辑。
Front Cell Infect Microbiol. 2025 Aug 19;15:1660446. doi: 10.3389/fcimb.2025.1660446. eCollection 2025.
2
Advances and Prospects of Fowl Adenoviruses Vaccine Technologies in the Past Decade.近十年禽腺病毒疫苗技术的进展与展望
Int J Mol Sci. 2025 Jul 4;26(13):6434. doi: 10.3390/ijms26136434.
3
The neonatal Fc receptor (FcRn): Guardian or Trojan Horse in viral infection?新生儿Fc受体(FcRn):病毒感染中的守护者还是特洛伊木马?

本文引用的文献

1
Recent progress on gene-deleted live-attenuated African swine fever virus vaccines.基因缺失的减毒活非洲猪瘟病毒疫苗的最新进展。
NPJ Vaccines. 2024 Mar 13;9(1):60. doi: 10.1038/s41541-024-00845-9.
2
RNA recognition by PKR during DNA virus infection.PKR 在 DNA 病毒感染过程中对 RNA 的识别。
J Med Virol. 2024 Feb;96(2):e29424. doi: 10.1002/jmv.29424.
3
Establishing a synthetic orthogonal replication system enables accelerated evolution in .建立一个合成的正交复制系统可以实现. 的快速进化。
PLoS Pathog. 2025 Jul 7;21(7):e1013285. doi: 10.1371/journal.ppat.1013285. eCollection 2025 Jul.
4
A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development.一种用于疫苗开发的高通量且稳健的相对效价测定方法,可测量上皮细胞中的人巨细胞病毒感染情况。
Vaccines (Basel). 2025 Jun 10;13(6):626. doi: 10.3390/vaccines13060626.
5
Accelerating vaccine development: Plug-and-play platforms for emerging infectious diseases.加速疫苗研发:针对新发传染病的即插即用平台
Virus Res. 2025 Jun 21;358:199601. doi: 10.1016/j.virusres.2025.199601.
6
EIAV encodes an accessory protein that antagonizes the host restriction factor equine tetherin.马传染性贫血病毒编码一种辅助蛋白,该蛋白可拮抗宿主限制因子马 tetherin。
Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2413703122. doi: 10.1073/pnas.2413703122. Epub 2025 Jun 23.
7
Recent advances on coxsackievirus A6 vaccine research.柯萨奇病毒A6疫苗研究的最新进展。
Front Immunol. 2025 Jun 6;16:1603028. doi: 10.3389/fimmu.2025.1603028. eCollection 2025.
8
Recent advances in the prevention and treatment of respiratory syncytial virus disease.呼吸道合胞病毒疾病预防与治疗的最新进展
J Gen Virol. 2025 Apr;106(4). doi: 10.1099/jgv.0.002095.
9
Editorial: Unveiling host-pathogen interactions: insights into animal cellular immunity and novel diagnostics.社论:揭示宿主-病原体相互作用:对动物细胞免疫和新型诊断方法的见解
Front Cell Infect Microbiol. 2025 Jan 15;14:1543349. doi: 10.3389/fcimb.2024.1543349. eCollection 2024.
10
The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs).动物病毒对抗宿主抗病毒天然免疫的策略:开发减毒活疫苗(LAVs)的新线索
Vaccines (Basel). 2025 Jan 8;13(1):46. doi: 10.3390/vaccines13010046.
Science. 2024 Jan 26;383(6681):421-426. doi: 10.1126/science.adk1281. Epub 2024 Jan 25.
4
Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines.新技术正在将梦想变为现实:有条件地复制病毒作为疫苗。
Trends Microbiol. 2024 Mar;32(3):292-301. doi: 10.1016/j.tim.2023.09.002. Epub 2023 Oct 3.
5
The Protective Efficacy of Single-Dose Nasal Immunization with Cold-Adapted Live-Attenuated MERS-CoV Vaccine against Lethal MERS-CoV Infections in Mice.单剂量鼻腔接种冷适应活减毒中东呼吸综合征冠状病毒疫苗对小鼠致死性中东呼吸综合征冠状病毒感染的保护效力
Vaccines (Basel). 2023 Aug 10;11(8):1353. doi: 10.3390/vaccines11081353.
6
Engineered bacterial orthogonal DNA replication system for continuous evolution.工程化的细菌正交 DNA 复制系统用于连续进化。
Nat Chem Biol. 2023 Dec;19(12):1504-1512. doi: 10.1038/s41589-023-01387-2. Epub 2023 Jul 13.
7
Progress on innate immune evasion and live attenuated vaccine of pseudorabies virus.伪狂犬病病毒先天免疫逃逸与减毒活疫苗研究进展
Front Microbiol. 2023 Mar 3;14:1138016. doi: 10.3389/fmicb.2023.1138016. eCollection 2023.
8
A novel viral vaccine platform based on engineered transfer RNA.基于工程转移 RNA 的新型病毒疫苗平台。
Emerg Microbes Infect. 2023 Dec;12(1):2157339. doi: 10.1080/22221751.2022.2157339.
9
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.减毒活麻疹病毒作为重组疫苗平台技术的多功能性。
NPJ Vaccines. 2022 Oct 15;7(1):119. doi: 10.1038/s41541-022-00543-4.
10
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.一种带有辅助蛋白缺失的活减 SARS-CoV-2 疫苗候选物。
Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z.